MedTrace Logo

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

NCT06596746 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-09-19

No results posted yet for this study

Summary

MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry tests will be analysed to carry out statistical investigations and predictive analyses, also using artificial intelligence systems, which allow the identification of new early markers of diagnosis and prognosis of neurodegenerative diseases.

Conditions

Interventions

OTHER

Observation

In MARKERS-NDD up to 600 participants will be enrolled and followed longitudinally once identified, over the course of 1-10 years

Sponsors & Collaborators

  • IRCCS San Raffaele Roma

    collaborator OTHER

  • San Raffaele Telematic University

    collaborator OTHER

  • University of Urbino "Carlo Bo"

    collaborator OTHER

  • University of Cassino and Southern Lazio

    collaborator UNKNOWN

  • University of Roma La Sapienza

    collaborator OTHER

  • Politecnico di Milano

    collaborator OTHER

  • Casa di Cura San Raffaele Cassino

    lead NETWORK

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-09
Primary Completion
2034-09-09
Completion
2034-09-09

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06596746 on ClinicalTrials.gov